BACKGROUND: Varicella zoster virus (VZV) causes chickenpox in children and zoster (zona) in the elderly. Using RFLP-PCR method for detection of VZV specific SNPs ORF38, 54 and 62 could distinguish the profile of VZV isolates. The aim of this study was to investigate enzymatic digestion pattern of VZV ORF38 and ORF54 in chickenpox patients using RFLP technique. METHODS: Thirty-eight chickenpox patients, who referred to the hospitals of Iran University of Medical Sciences in Tehran from May 2010 to June 2015 were enrolled in this cross sectional study. After the DNA extraction, PCR amplification of 38 VZV isolates performed by specific primers of ORFs 38 and 54, then RFLP assay and digestion carried out by PstI (for ORF38) and BglI (for ORF54) restriction enzymes. RESULTS: Of 38 positive VZV DNA, the mean age (yr)±SD was 34.4±23.3 (range: 7-89). 22 (57.9%) were female and 16 (42.1%) were male. The predominant VZV profile of BglI(+) PstI(+) were 89.5% (34/38) followed by 10.5% (4/38) PstI(+) BglI‾. Statistical analysis showed that there was no significant relationship between genotype, age, sex, and year of infection variables (P value> 0.05). The common VZV genotype among Iranian patients with chickenpox and zona infection is genotype BglI(+) PstI(+) followed by PstI(+) BglI‾. CONCLUSION: There are different VZV circulating genotypes that call for for more research on this field by widely population and other methods such as nucleotide sequencing to justify the accurate VZV genotype prevalence in Iran.
BACKGROUND:Varicella zoster virus (VZV) causes chickenpox in children and zoster (zona) in the elderly. Using RFLP-PCR method for detection of VZV specific SNPs ORF38, 54 and 62 could distinguish the profile of VZV isolates. The aim of this study was to investigate enzymatic digestion pattern of VZVORF38 and ORF54 in chickenpox patients using RFLP technique. METHODS: Thirty-eight chickenpox patients, who referred to the hospitals of Iran University of Medical Sciences in Tehran from May 2010 to June 2015 were enrolled in this cross sectional study. After the DNA extraction, PCR amplification of 38 VZV isolates performed by specific primers of ORFs 38 and 54, then RFLP assay and digestion carried out by PstI (for ORF38) and BglI (for ORF54) restriction enzymes. RESULTS: Of 38 positive VZV DNA, the mean age (yr)±SD was 34.4±23.3 (range: 7-89). 22 (57.9%) were female and 16 (42.1%) were male. The predominant VZV profile of BglI(+) PstI(+) were 89.5% (34/38) followed by 10.5% (4/38) PstI(+) BglI‾. Statistical analysis showed that there was no significant relationship between genotype, age, sex, and year of infection variables (P value> 0.05). The common VZV genotype among Iranian patients with chickenpox and zona infection is genotype BglI(+) PstI(+) followed by PstI(+) BglI‾. CONCLUSION: There are different VZV circulating genotypes that call for for more research on this field by widely population and other methods such as nucleotide sequencing to justify the accurate VZV genotype prevalence in Iran.
Varicella zoster virus (VZV) is a herpes virus that causes chickenpox (varicella) and shingles (zoster) (1, 2). The primary infection in children causes varicella or chickenpox that is one of the six exanthemas of childhood. Elderly infection results in painful complications with some skin lesions, called zona or shingles (3, 4). Chickenpox is one of the major childhood diseases that is prevalent in temperate zones with significant mortality (1, 5). Children may be hospitalized for chickenpox by 2-4%, with a mortality rate of 0 to 0.05 per 100,000 cases. Neuralgia pain and sometimes morbidity and mortality of Herpes zoster in the elderly (>50 yr ages) is due to reactivation of latent VZV infection in dorsal root of ganglia (1, 3, 4, 6).A live attenuated vaccine, called Oka, is created by a Japanese scientist, Takahashi in 1970s, povides a long-lasting protection in the introduced countries and decreases the spread of VZV infection dramatically (7-9). In order to use the live attenuated vaccine, surveillance of circulating strains is important (7, 10). Phylogenetic tree of VZV strains by sequence analysis demonstrates different genotypes that categorized in distinct clades globally, although the virulence genetic markers of circulating strains are unknown (11). Furthermore, homologous recombination effects on VZV evolution. Analyzing one or a few loci could distinguish the VZV genotypes (11). There are various methods to differentiate wild type (WT) and vaccine VZV strains, including single stranded conformational polymorphism analysis, long PCR, PCR-RFLP analysis, and Light Cycler Real-Time PCR; although Restriction Fragment Length Polymorphism (RFLP) is the original method and PCR-RFLP widely used (6, 12, 13).There are three salient single nucleotide polymorphisms (SNPs) in VZV vaccine surveillance and epidemiological studies that could be distinguished by the RFLP analysis, like open reading frames (ORFs) 38, 54, and 62, each of which had a specific silent base mutation at position 943 (A to G), 744 (C to T), and 2872 (C to T) alleles; these were used to determine the digestion pattern profiles by PstI (for ORF 38), BglI (for ORF 54) and SmaI (for ORF 62) restriction enzymes, respectively (10, 14, 15).PstI positive strains (BglI/SmaI negative) were dominant in the Europe and the North America in that wild type strains, PstI and BglI positive strains (SmaI negative) contain the Oka like strains and African or Asian strains (10). The specific restriction site of the varicella vaccine strains (vOka) was SmaI that located on ORF 62. Thus, RFLP could be used to distinguish strains from WT, vaccine, and or their geographical dominance (10, 16).The aim of the prospective study was to distinguish wild type or vaccine strains of VZV by enzymatic digestion pattern of ORF38 and ORF54 in chickenpox patients using RFLP technique which prepared for the first time in Iran.
Patients:The mean age (yr)±SD of 38 positive VZV DNA isolates was 34.4±23.3 (Range: 7-89 yr), 42.1% were male and 57.9% were female. Table 1 indicates the demographic characteristics and laboratory parameters.
Table1
Demographic characteristics, laboratory parameters of positive VZV DNA isolates
Year
2010
2011
2012
2013
2014
2015
Total
Total No.
2
6
2
6
12
10
38
Male/Female
2/0
4/2
2/0
0/6
6/6
2/8
16/22
Age(y), Mean±SD
39.3±36.8
25.8±24.5
38.6±19.3
20.5±17.6
46.3±21.1
23.0±14.9
34.4±23.3
Demographic characteristics, laboratory parameters of positive VZV DNA isolatesPCR-RFLP:The PCR products of 38 VZV-DNA positive was confirmed by appropriate markers and VZV positive controls (Fig. 1). RFLP analyses of ORF54 by specific restriction enzymes showed that all 34 isolates were cleaved by BglI enzyme into 255, 242 bp fragments (89.5% BglI+) and 4 were negative (10.5% BglI¯). Digestion of ORF 38 by PstI restriction enzyme illustrated that all isolates were cleaved into 357, 290 bp fragments (100% PstI+) as visualized by 2% Agarose gel electrophoresis (Fig. 2). There were no PstI¯ isolates.
Fig. 1
Some of the confirmed PCR products of ORF 38 for RFLP.
Fig. 2
Digestion of some PCR products of ORF 38 and 54 by PstI and BglI restriction enzymes. (30-35: samples, C+: control positive, C-: control negative, L: Ladder
Statistical analysis revealed that there were no significant correlations between the genotype, age, and sex variables (P value> 0.05).Some of the confirmed PCR products of ORF 38 for RFLP.Digestion of some PCR products of ORF 38 and 54 by PstI and BglI restriction enzymes. (30-35: samples, C+: control positive, C-: control negative, L: Ladder
Discussion
Actually, childhood exanthema and elderly neuralgia with significant skin lesions is caused by the varicella-zoster virus infection (18, 19). Live attenuated Oka vaccine declined the occurrence of chickenpox in communities (20). Reactivation of VZV in order to zona presentation could be decreased by use of vaccination (9, 20). Vaccination of individuals could spread the VZV vOka strain to regions that already had other predominant strains (20). Furthermore, the VZV dominant genotypes monitoring and molecular surveillance of circulating strains is important (13, 20) even for areas without VZV vaccine or in processing program countries such as Iran.Generally, genotyping of VZV strains was discussed by different strategies (21). One of them is RFLP-PCR genotyping which carried out by digestion profile of VZVORF 38, 54, and 62 with PstI, BglI and SmaI restriction enzymes. The RFLP-PCR method could distinguish wild type strains from vaccine derived strains (6, 10, 20, 22). Digestion pattern of VZV strains represents their genotype. Digestion pattern of Oka vaccine strains PstI‾BglI+SmaI+, Japanese Oka like wild type strains PstI‾/PstI+BglI+SmaI‾, African and Asian wild type strains BglI+, North America and Europe PstI+BglI‾; PstI‾BglI‾ has not been identified so far (Table2) (15, 16, 20-24). In comparison with our results which 34 isolates digestion profile PstI+BglI+ similar to other African/Asian or Oka like wild type strains (pOka), 2 isolates were PstI+BglI‾ like American/European strains and there were no isolates containing Oka vaccine strains (PstI‾ BglI+).In the present study, the PCR-RFLP method was used to analyze the varicella-zoster virus genotype by investigation of digestion profile for the first time in Iran. There are some studies on antibody prevalence in different populations in Iran which report VZV specific antibodies are about 70% to 90%, so, there has not been any data from Iranian circulating VZV genotypes, respectively (5, 18, 19).According to different genotyping strategies, scientists have been introduced a different nomenclature of genotypes (20). A method was described by Loparev et al. used Single Nucleotide Polymorphism of ORFs 38 (PstI) and 54 (BglI) along with sequencing the short region of ORF 22 (447 bp) (25). In this method three genotypes and some subgenotypes were distinctive. The major and minor genotypes are J, E (E1, E2) and M (M1, M2, M3 and M4) (25, 26). Every genotype has a particular geographical distribution, although some regions may contain a mixture of them. Moreover, every genotype has a certain profile of digestion by PstI and BglI restriction enzymes (25).According to genotyping strategy of Loparev et al., the M genotype strains have PstI+BglI+ digestion profile (21) and is assumed to be reproduced by combination of J and E genotypes (13, 16, 21); The J genotype strains (Japanese Oka like wild type strains) have PstI‾/PstI+BglI+ digestion profile. (13, 16, 21). In this paper, we detected the predominant 89.5% (34/38) PstI+BglI+ that could be the M or J genotype. The M genotype is dominant in tropical and subtropical zone like Africa (Chad, DRC and Morocco), South America, Western Australia and Asia (Nepal, India, China and Bangladesh) (21, 22); and the J genotype is dominant in Japan and other Eastern and Asian countries and Australia. Asian immigrant of Western North America and Australia were exposed to the imported strains (16, 21, 25).Our results showed that we have 10.5% (4/38) PstI+BglI‾ strains which the E genotype strains uniformly bear the PstI+BglI‾ marker based on Loparev et al. studies (13, 16, 21). The E genotype strains are dominant genotype in Europe, Eastern Australia, Asian Russia, Kazakhestan, Canada, and the United States (16, 21, 25). This could show another circulating genotype of our country and could be due to the high level of migration to Europe and/or other countries that E genotype is dominant.
Conclusion:
These data are indicative of the presence of some diversity in VZV genotypes of our population, moreover, nucleotide sequencing could be combined with RFLP-PCR for better detection. Results suggest that we need to increase the basic concept of our VZV genotypes and more research stidues are required for this topic. Monitoring of circulating VZV genotypes is vital, particularly for initiation of vaccination program and these data call for investigation in a broader number of specimens for confirmation.
Authors: Vladimir N Loparev; Antonio Gonzalez; Marlene Deleon-Carnes; Graham Tipples; Helmut Fickenscher; Einar G Torfason; D Scott Schmid Journal: J Virol Date: 2004-08 Impact factor: 5.103
Authors: Vladimir N Loparev; Elena N Rubtcova; Vanda Bostik; Valentina Tzaneva; Andreas Sauerbrei; Alma Robo; Eva Sattler-Dornbacher; Iva Hanovcova; Vera Stepanova; Miroslav Splino; Vladimir Eremin; Marjaleena Koskiniemi; Olga E Vankova; D Scott Schmid Journal: Virology Date: 2008-11-20 Impact factor: 3.616
Authors: M Brisson; W J Edmunds; B Law; N J Gay; R Walld; M Brownell; L L Roos; G DE Serres Journal: Epidemiol Infect Date: 2014-08-13 Impact factor: 4.434
Authors: Lucy A Weinert; Daniel P Depledge; Samit Kundu; Anne A Gershon; Richard A Nichols; Francois Balloux; John J Welch; Judith Breuer Journal: Mol Biol Evol Date: 2015-01-06 Impact factor: 8.800